Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act; H.R. 1865 FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), Pub. L. No. 116-94.
FY 2020 Labor-HHS and Defense appropriations HR 2740; H.R. 1865 FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), Pub. L. No. 116-94
Reauthorization of the CW Bill Young Cell Transplantation Program and National Cord Blood Inventory; H.R. 3520 "Stem Cell Therapeutic and Research Reauthorization Act of 2019"; regenerative medicine issues; H.R. 4764, the TRANSPLANT Act
Duration: January 6, 2014
to
December 31, 2019
General Issues: Medicare/Medicaid , Budget/Appropriations , Health Issues
Spending: about $1,539,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2019
Lester Health Law PLLC terminated an engagement in which they represented National Marrow Donor Program on Jan. 20, 2020.
Original Filing: 301123253.xml
Lobbying Issues
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act; H.R. 1865 FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), Pub. L. No. 116-94.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Labor-HHS and Defense appropriations HR 2740; H.R. 1865 FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), Pub. L. No. 116-94
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the CW Bill Young Cell Transplantation Program and National Cord Blood Inventory; H.R. 3520 "Stem Cell Therapeutic and Research Reauthorization Act of 2019"; regenerative medicine issues; H.R. 4764, the TRANSPLANT Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Oct. 26, 2019.
Original Filing: 301080158.xml
Lobbying Issues
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Labor-HHS and Defense appropriations HR 2740
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the CW Bill Young Cell Transplantation Program and National Cord Blood Inventory; H.R. 3520 "Stem Cell Therapeutic and Research Reauthorization Act of 2019"; regenerative medicine issues
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on July 26, 2019.
Original Filing: 301060112.xml
Lobbying Issues
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Labor-HHS and Defense appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the CW Bill Young Cell Transplantation Program and National Cord Blood Inventory; H.R. 3520 "Stem Cell Therapeutic and Research Reauthorization Act of 2019"; regenerative medicine issues
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on April 19, 2019.
Original Filing: 301031958.xml
Lobbying Issues
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Labor-HHS and Defense appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the CW Bill Young Cell Transplantation Program and National Cord Blood Inventory (no legislation yet introduced); Implementation of H.R. 2820, Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Pub. L. No. 114-104); regenerative medicine issues
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Jan. 22, 2019.
Original Filing: 301017891.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule; HR 4215, Protect Access to Cellular Transplantation Act; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Labor-HHS Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; H.J.Res.123 Continuing Resolution; H.R.1370 Continuing Resolution; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Defense appropriations -- HR 6157 "Department of Defense Appropriations Act, 2019" and S. 3159 -- "Department of Defense Appropriations Act, 2019"; FY 2019 Labor-HHS appropriations -- House Subcommittee Draft (no number has been posted) and S. 3158 -- "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104); Regenerative Medicine legislation; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); H.R.6157, DOD appropriations
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992884.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule; HR 4215, Protect Access to Cellular Transplantation Act; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Labor-HHS Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; H.J.Res.123 Continuing Resolution; H.R.1370 Continuing Resolution; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Defense appropriations -- HR 6157 "Department of Defense Appropriations Act, 2019" and S. 3159 -- "Department of Defense Appropriations Act, 2019"; FY 2019 Labor-HHS appropriations -- House Subcommittee Draft (no number has been posted) and S. 3158 -- "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104); Regenerative Medicine legislation; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); H.R.6157, DOD appropriations
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on July 21, 2018.
Original Filing: 300978845.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule; HR 4215, Protect Access to Cellular Transplantation Act; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Labor-HHS Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; H.J.Res.123 Continuing Resolution; H.R.1370 Continuing Resolution; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018); FY 2019 Defense appropriations -- HR 6157 "Department of Defense Appropriations Act, 2019" and S. 3159 -- "Department of Defense Appropriations Act, 2019"; FY 2019 Labor-HHS appropriations -- House Subcommittee Draft (no number has been posted) and S. 3158 -- "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104); Regenerative Medicine legislation; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018)
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on April 20, 2018.
Original Filing: 300958268.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule; HR 4215, Protect Access to Cellular Transplantation Act; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018)
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; H.J.Res.123 Continuing Resolution; H.R.1370 Continuing Resolution; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104); Regenerative Medicine legislation; H.R.195 (Continuing Resolution (through February 8, 2018)); H.R.1301 (Continuing Resolution); H.R.1625 (Vehicle for Consolidated Appropriations Act 2018)
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Jan. 22, 2018.
Original Filing: 300937140.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule; HR 4215, Protect Access to Cellular Transplantation Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; H.J.Res.123 Continuing Resolution; H.R.1370 Continuing Resolution
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104); Regenerative Medicine legislation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911242.xml
Lobbying Issues
Inpatient hospital prospective payment system proposed and final rule; hospital outpatient prospective payment system proposed rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 appropriations (LHHS, Defense) -- H.R.3354 "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018"; H.R.3219 "Make America Secure Appropriations Act, 2018"; H.R.3358 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"; S.1771 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on July 20, 2017.
Original Filing: 300897631.xml
Lobbying Issues
Inpatient hospital prospective payment system; hospital outpatient prospective payment system
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2017 and FY 2018 appropriations (LHHS, Defense); FY 2017 and FY 2018 appropriations (LHHS, Defense)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104).
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on April 20, 2017.
Original Filing: 300877927.xml
Lobbying Issues
Inpatient hospital prospective payment system
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2017 appropriations (LHHS, Defense); FY 2018 appropriations (LHHS, Defense)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2820, "Stem Cell Therapeutic and Research Reauthorization Act of 2015" (Pub. L. No. 114-104).
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Jan. 23, 2017.
Original Filing: 300854610.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed and Final Rules; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HHS appropriations for bone marrow and cord blood programs; H.R.2028 Further Continuing and Security Assistance Appropriations Act; H.R.5325 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act; H.R.5926 and S.3040, Labor/HHS/Education appropriations legislation; H.R.5293 and S.3000 Defense appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; S. 2689, the REGROW Act; implementation of the Affordable Care Act, implementation of the reauthorization of the CW Bill Young Cell Transplantation Program, the REGROW Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Oct. 20, 2016.
Original Filing: 300839908.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HHS appropriations for bone marrow and cord blood programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; S. 2689, the REGROW Act; implementation of the Affordable Care Act, implementation of the reauthorization of the CW Bill Young Cell Transplantation Program, the REGROW Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on July 19, 2016.
Original Filing: 300815707.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HHS appropriations for bone marrow and cord blood programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; S. 2689, the REGROW Act; implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on April 20, 2016.
Original Filing: 300803521.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HHS appropriations for bone marrow and cord blood programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; S. 2689, the REGROW Act; implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $69,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784214.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HR 2029 Omnibus appropriations; HR 3020 & S 1695 Labor-HHS appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act of 2015; S. 2822 Stem Cell Therapeutic and Research Reauthorization Act of 2015; general reauthorization of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $65,750. The report was filed on Oct. 20, 2015.
Original Filing: 300759257.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease and Myelofibrosis) (CAG-00444R)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act of 2015; general reauthorization of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $52,750. The report was filed on July 20, 2015.
Original Filing: 300740521.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease and Myelofibrosis) (CAG-00444R)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6, the 21st Century Cures Act; H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act of 2015; general reauthorization of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $49,500. The report was filed on April 20, 2015.
Original Filing: 300722020.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program
Agencies Lobbied
U.S. Senate
Lobbying Issues
HRSA Proposed Rule: Change to the Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984; 21st Century Cures initiative
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $49,500. The report was filed on Jan. 20, 2015.
Original Filing: 300708088.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.J.Res 124 Continuing Appropriations Resolution, 2015; H.R. 4870 Department of Defense Appropriations Act, 2015; House and Senate Department of Labor, Health and Human Services, and Education Appropriations legislation; H.J.Res.130 FY2015 Continuing Resolution; H.J.Res.131 Making further continuing appropriations for fiscal year 2015, and for other purposes; and H.R.83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of P.L. 111-148 Patient Protection and Affordable Care Act; H.R. 589 To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes; HRSA Proposed Rule: Change to the Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $49,500. The report was filed on Oct. 19, 2014.
Original Filing: 300682467.xml
Lobbying Issues
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.J.Res 124 Continuing Appropriations Resolution, 2015; H.R. 4870 Department of Defense Appropriations Act, 2015; House and Senate Department of Labor, Health and Human Services, and Education Appropriations legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of P.L. 111-148 Patient Protection and Affordable Care Act; H.R. 589 To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes; HRSA Proposed Rule: Change to the Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $49,500. The report was filed on July 21, 2014.
Original Filing: 300664276.xml
Lobbying Issues
Reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Rule; Hospital Inpatient Rule
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
Lester Health Law PLLC amended a lobbying report for representation of National Marrow Donor Program in Q22014 on July 21, 2014.
Original Filing: 300664281.xml
Lobbying Issues
Reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Rule; Hospital Inpatient Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of P.L. 111-148 Patient Protection and Affordable Care Act; H.R. 589 To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes; HRSA Proposed Rule: Change to the Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, Lester Health Law PLLC lobbied for National Marrow Donor Program , earning $49,500. The report was filed on April 16, 2014.
Original Filing: 300638179.xml
Lobbying Issues
Implementation of P.L. 111-148 Patient Protection and Affordable Care Act; H.R. 589 To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes; HRSA Proposed Rule: Change to the Definition of "Human Organ" Under Section 301 of the National Organ Transplant Act of 1984
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare coverage and reimbursement for bone marrow and cord blood transplantation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Defense and Department of Health and Human Services FY 2014 Appropriations for C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory;
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
Lester Health Law PLLC filed a lobbying registration on April 8, 2014 to represent National Marrow Donor Program, effective Jan. 6, 2014.
Original Filing: 300633335.xml
Issue(s) they said they’d lobby about: Public Health funding, Medicare, and Affordable Care Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...